Ticker Details
Bioventus Inc.
IPO Date:	February 11, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$982.23M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.41%
Avg Daily Range (30 D):	$0.46 | 3.52%
Avg Daily Range (90 D):	$0.38 | 3.47%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	309
Avg Institutional Trade:	$1.23M
Avg Institutional Trade (30 D):	$1.05M
Avg Institutional Trade (90 D):	$.99M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.31M
Avg Closing Trade (30 D):	$1.1M
Avg Closing Trade (90 D):	$.99M
Avg Closing Volume:	139.88K

News

Jun 2, 2026 @ 11:00 AM Bioventus to Present at the Goldman Sachs 47TH Ann... Source: Na

May 22, 2026 @ 2:31 PM Regenerative Medicine's Newest Public Company Is B... Source: Usa News Group

Mar 12, 2026 @ 7:45 AM Orthobiologics Market to Surpass USD 9 Billion by ... Source: Mordor Intelligence

Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford

Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.81	$.49	$.05
Diluted EPS	$.78	$.47	$.04
Revenue	$581.85M	$153.21M	$132.09M
Gross Profit	$399.45M	$105.67M	$90.77M
Net Income / Loss	$61.48M	$36.21M	$3.95M
Operating Income / Loss	$58.28M	$19.13M	$8.42M
Cost of Revenue	$182.4M	$47.54M	$41.32M
Net Cash Flow	$-3.45M	$-6.39M	$-15.39M
PE Ratio